U
Biofrontera AG BIFRF
OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
$16.08M
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
$0.37
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$26.04M
Total Debt (Q)
$2.16M
Total Liabilities (Q)
$6.46M
Book Value Per Share (Q)
$3.22
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Friday, May 29, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Nov 23 and 27 (est)
Price History
Loading...
Beta
--
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
-- - --
52-week High
-- - --
Valuation
Market Cap
$16.08M - Nano Cap
Enterprise Value
$11.83M
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
6.11M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.biofrontera.com
Phone Number
49 214 87632 0
Address
Hemmelrather Weg 201
Leverkusen, 51377
Country
Germany
Year Founded
1997
Business Description
Sector
--
Industry
--
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of... more